Frontiers in Immunology (May 2025)
Long COVID-19 autoantibodies and their potential effect on fertility
- Laura Talamini,
- Dennyson Leandro M. Fonseca,
- Darja Kanduc,
- Olivier Chaloin,
- Cindy Verdot,
- Christian Galmiche,
- Arad Dotan,
- Igor Salerno Filgueiras,
- Maria Orietta Borghi,
- Maria Orietta Borghi,
- Pier Luigi Meroni,
- Natalia Y. Gavrilova,
- Varvara A. Ryabkova,
- Varvara A. Ryabkova,
- Leonid P. Churilov,
- Leonid P. Churilov,
- Gilad Halpert,
- Gilad Halpert,
- Christian Lensch,
- Lorenz Thurner,
- Siew-Wai Fong,
- Lisa F.P. Ng,
- Laurent Rénia,
- Laurent Rénia,
- Laurent Rénia,
- Barnaby E. Young,
- Barnaby E. Young,
- Barnaby E. Young,
- David Chien Lye,
- David Chien Lye,
- David Chien Lye,
- David Chien Lye,
- José Manuel Lozano,
- Otávio Cabral-Marques,
- Otávio Cabral-Marques,
- Otávio Cabral-Marques,
- Otávio Cabral-Marques,
- Otávio Cabral-Marques,
- Otávio Cabral-Marques,
- Otávio Cabral-Marques,
- Yehuda Shoenfeld,
- Yehuda Shoenfeld,
- Sylviane Muller,
- Sylviane Muller
Affiliations
- Laura Talamini
- CNRS UMR7242 Biotechnology and Cell Signalling, University of Strasbourg/Strasbourg Drug Discovery and Development Institute (IMS), Strasbourg, France
- Dennyson Leandro M. Fonseca
- Interunit Postgraduate Program on Bioinformatics, Institute of Mathematics and Statistics (IME), University of São Paulo (USP), São Paulo, Brazil
- Darja Kanduc
- Department of Biosciences Biotechnologies and Biopharmaceutics, University of Bari, Bari, Italy
- Olivier Chaloin
- CNRS UPR3572 Immunology, Immunopathology and Therapeutic Chemistry, Institut de Biologie Moléculaire et Cellulaire (IBMC), Strasbourg, France
- Cindy Verdot
- CNRS UMR7242 Biotechnology and Cell Signalling, University of Strasbourg/Strasbourg Drug Discovery and Development Institute (IMS), Strasbourg, France
- Christian Galmiche
- UAR3415, Chronobiotron, Strasbourg, France
- Arad Dotan
- Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Ramat-Gan, Israel
- Igor Salerno Filgueiras
- Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil
- Maria Orietta Borghi
- Department of Clinical Sciences and Community Health, University of Milan, Milano, Italy
- Maria Orietta Borghi
- Experimental Laboratory of Immunological and Rheumatologic Researches, Istituto Auxologico Italiano Istituto di Ricovero e Cura a Carattere Scientifico, Milano, Italy
- Pier Luigi Meroni
- Experimental Laboratory of Immunological and Rheumatologic Researches, Istituto Auxologico Italiano Istituto di Ricovero e Cura a Carattere Scientifico, Milano, Italy
- Natalia Y. Gavrilova
- 0Department of Pathology and Laboratory of the Mosaic of Autoimmunity, Saint Petersburg State University, Saint-Petersburg, Russia
- Varvara A. Ryabkova
- 0Department of Pathology and Laboratory of the Mosaic of Autoimmunity, Saint Petersburg State University, Saint-Petersburg, Russia
- Varvara A. Ryabkova
- 1Pavlov First Saint Petersburg State Medical University, Saint-Petersburg, Russia
- Leonid P. Churilov
- 0Department of Pathology and Laboratory of the Mosaic of Autoimmunity, Saint Petersburg State University, Saint-Petersburg, Russia
- Leonid P. Churilov
- 2Research Institute of Phthisiopulmonology, Saint-Petersburg, Russia
- Gilad Halpert
- Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Ramat-Gan, Israel
- Gilad Halpert
- 0Department of Pathology and Laboratory of the Mosaic of Autoimmunity, Saint Petersburg State University, Saint-Petersburg, Russia
- Christian Lensch
- 3Department of Pneumology, Allergology and Critical Care Medicine, ECLS Center Saar, Saarland University Hospital, Homburg/Saar, Germany
- Lorenz Thurner
- 4José Carreras Center for Immuno and Gene Therapy and Department of Internal Medicine I, Saarland University, Homburg, Germany
- Siew-Wai Fong
- 5ASTAR Infectious Diseases Labs, Agency for Science, Technology and Research (ASTAR), Singapore, Singapore
- Lisa F.P. Ng
- 5ASTAR Infectious Diseases Labs, Agency for Science, Technology and Research (ASTAR), Singapore, Singapore
- Laurent Rénia
- 5ASTAR Infectious Diseases Labs, Agency for Science, Technology and Research (ASTAR), Singapore, Singapore
- Laurent Rénia
- 6Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore
- Laurent Rénia
- 7School of Biological Sciences, Nanyang Technological University, Singapore, Singapore
- Barnaby E. Young
- 6Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore
- Barnaby E. Young
- 8National Centre for Infectious Diseases, Singapore, Singapore
- Barnaby E. Young
- 9Tan Tock Seng Hospital, Singapore, Singapore
- David Chien Lye
- 6Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore
- David Chien Lye
- 8National Centre for Infectious Diseases, Singapore, Singapore
- David Chien Lye
- 9Tan Tock Seng Hospital, Singapore, Singapore
- David Chien Lye
- 0Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
- José Manuel Lozano
- 1Universidad Nacional de Colombia-Sede Bogotá, Departamento de Farmacia, Mimetismo Molecular de los Agentes Infecciosos, Bogotá, DC, Colombia
- Otávio Cabral-Marques
- Interunit Postgraduate Program on Bioinformatics, Institute of Mathematics and Statistics (IME), University of São Paulo (USP), São Paulo, Brazil
- Otávio Cabral-Marques
- Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil
- Otávio Cabral-Marques
- 2Network of Immunity in Infection, Malignancy, and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), São Paulo, Brazil
- Otávio Cabral-Marques
- 3Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil
- Otávio Cabral-Marques
- 4Instituto D’Or de Ensino e Pesquisa, São Paulo, Brazil
- Otávio Cabral-Marques
- 5Department of Clinical and Toxicological Analyses, Faculty of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil
- Otávio Cabral-Marques
- 6Department of Medicine, Division of Molecular Medicine, Laboratory of Medical Investigation 29, University of São Paulo School of Medicine, São Paulo, Brazil
- Yehuda Shoenfeld
- Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Ramat-Gan, Israel
- Yehuda Shoenfeld
- 7Reichman University, Herzelya, Israel
- Sylviane Muller
- CNRS UMR7242 Biotechnology and Cell Signalling, University of Strasbourg/Strasbourg Drug Discovery and Development Institute (IMS), Strasbourg, France
- Sylviane Muller
- 8University of Strasbourg Institute for Advanced Study (USIAS), Strasbourg, France
- DOI
- https://doi.org/10.3389/fimmu.2025.1540341
- Journal volume & issue
-
Vol. 16
Abstract
Impaired spermatogenesis has been reported in coronavirus disease 2019 (COVID-19) patients. However, the impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on male fertility remains unclear. The purpose of this multicenter study was to investigate the possible impact of SARS-CoV-2 infection on male fertility and determine the potential reasons leading to impaired male reproductive functions. In silico approach identified ~60 amino acid sequences containing at least five continuous residues shared by SARS-CoV-2 Spike glycoprotein and spermatogenesis-linked proteins. Four synthetic peptides were tested with sera from independent cohorts of patients with acute and long COVID-19 syndrome (LCS), and naïve vaccinated subjects. Immunogenicity and pathogenicity studies were performed by immunizing mice with two selected peptides and testing the antigenicity of induced antibodies. While none of four peptides were recognized by antibodies from vaccinated people, infected patients exhibited high reactivity to peptide 4, and LCS patients, especially women, showed elevated antibody levels against peptide 2. Women with LCS and chronic fatigue syndrome had higher levels of peptide 2–reacting antibodies than those with idiopathic chronic fatigue syndrome. Noteworthy, peptide 2 antibodies showed, in in vitro experiment, a specific interaction with mouse testicular tissue antigens. These findings raise the possibility that cross-reactive epitopes between SARS-CoV-2 Spike protein and spermatogenesis-related antigens may affect infected patients’ fertility, suggesting a potential for autoimmune responses with human consequences.
Keywords
- autoantibodies
- peptide sequence identity
- male reproductive system
- coronavirus infection
- post-COVID-19 condition